KEYMAKER-U01 Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)
NCT06780098 · RECRUITING · Phase 2
ReadTheTrial indexes 2 studies for Lung Neoplasm. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
2 clinical trials found for Lung Neoplasm.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 50% |
| N/A | 1 | 50% |
There are 2 clinical trials listed for Lung Neoplasm. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Lung Neoplasm trials are distributed across: Phase 2 (1), N/A (1).